Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2021

View Archived Issues

Urinary follistatin useful to monitor AKI severity

Researchers develop a cystic fibrosis-related diabetes murine model

Roche describes new cyclic GMP-AMP synthase inhibitors

Janssen identifies NLRP3 inflammasome inhibitors

New GTPase KRAS mutant inhibitors discovered at Incyte

Aryl hydrocarbon receptor modulators discovered at Dong-A ST

New JAK inhibitors patented by Gossamer Bio

Mineralocorticoid receptor antagonism ameliorates DKD phenotype in mice

Viking Therapeutics' dual GLP-1/GIP receptor agonists show potential in model of obesity

Novel UOX-iKO mouse as model of hyperuricemia

RBT-9 shown effective against BK virus infection

STAR-0215, a potent and long-acting MAb plasma kallikrein inhibitor for the treatment of HAE

Analysis of lung phenotype in rat CF models using flexiVent and X-ray velocimetry

Novel small molecule K+ secretagogue RDX-013 for treating hyperkalemia

Antibody discovery platform increases cancer immunotherapy targets

Studies of KL-11743 detail potential oncolytic activity of glucose transporter inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.